Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Operating Expenses | 331 | 330 | 670 | 412 | 392 |
| Operating Income | -331 | -330 | -670 | -412 | -392 |
| Interest Expense | 0 | 0 | 0 | 4 | 0 |
| Other Income | 1 | 4 | 5 | 0 | 1 |
| Pre-tax Income | -331 | -326 | -664 | -416 | -391 |
| Net Income Continuous | -331 | -326 | -664 | -416 | -391 |
| Net Income | $-331 | $-326 | $-664 | $-416 | $-391 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.04 | 0.00 | -0.04 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.04 | 0.00 | -0.04 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.04 | 0.00 | -0.04 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.04 | 0.00 | -0.04 |
| EBITDA(a) | $-322 | $-317 | $-655 | $-402 | $-380 |